It is contraindicated in patients with liver failure, pancreatitis, inborn disorders of fat metabolism, primary carnitine deficiency, carnitine palmitoyl transferase deficiency, carnitine translocase deficiency, porphyria, and pyruvate kinase deficiency
Hair loss affects approximately 3% of users due to rapid weight loss, while eye issues (diabetic retinopathy worsening) occur in 1.6% of diabetic patients
Contact Sperling Dermatology today to schedule your consultation and learn more about our Body by Sperling, Powered by Semaglutide program
Valid identification and proof of a permanent local address
It comes in oral and injectable forms
Other Ingredients: Cellulose, Vegetable Cellulose Capsule and Organic Rice Extract Blend